Due to the recent growth of the pharmaceutical industry, the value of highly-sensitive data stored in pharmaceutical systems and the degree of the potential damage that cyberattacks on the industry can cause, it is safe to say that pharma could be one of the most targeted industries by cybercriminals in 2023. Ransomware, phishing attacks, business applications and third-party vendors will be some of the biggest threats to this key vertical as we approach the new year.
RansomwareThe threat of
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
M&A: Accenture Acquires Life Sciences Consulting Firm Bionest
What You Should Know:
- Today, Accenture announced it has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions for leading biopharma organizations across innovative areas of science including precision medicine and diagnostics, oncology, cell & gene therapy (CGT), and rare diseases. Terms of the transaction were not disclosed.
- Scientific and technological advancements are creating breakthroughs for patient health,
Read More
M&A: Science 37 Acquires Vault Health’s Life Sciences Platform
What You Should Know:
- Science 37 Holdings, Inc., the industry-leading Metasite announced it has acquired life sciences platform from Vault Health, a national leader in remote diagnostics and COVID testing, to further enhance clinical trial workflow orchestration and data interoperability capabilities of the Science 37 platform.
- The asset purchase accelerates Science 37’s existing development plans for workflow features such as advanced scheduling and investigational product tracking,
Read More
ProKidney Taps CVS Health Clinical Trial Services for Precision Recruitment
What You Should Know:
- CVS Health Clinical Trial Services and late clinical-stage cellular therapeutics company ProKidney Corp. today announced a collaboration to enroll patients with type 2 diabetes and chronic kidney disease into the proact 1 (REGEN-006) Phase 3 clinical trial of REACT®.
ProKidney’s lead product candidate, REACT® (REnal Autologous Cell Therapy), is a first-of-its-kind, patented, autologous cellular therapy with the potential to not only slow and stabilize the
Read More
Curebase Launches Remote First DTx Research Platform
What You Should Know:
- Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics (DTx) trials that accelerates enrollment and allows sponsors to launch their studies faster.
- Available now, the new Curebase offering includes the first one-stop-shop decentralized clinical trial (DCT) platform bundled with site and trial execution services for the DTx market.
Making
Read More
Paradigm Launches with $203M to Improve Clinical Research Access
What You Should Know:
- Paradigm, a healthcare technology company focused on improving access to clinical research for patients, launched with $203 million in Series A funding.
- Conceived by ARCH Venture Partners, and co-incubated by ARCH and General Catalyst, Paradigm is rebuilding the clinical research ecosystem by creating a technology-forward clinical trial platform that enables equitable access for all patients by enhancing trial efficiency and reducing the barriers to participation
Read More
Boosting Clinical Trial Recruitment Requires Humanity – and Technology
Clinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, researchers, and drug developers deal with the many barriers to clinical trial recruitment and access.
There are two central – and intrinsically linked – problems with the current state of clinical trial recruitment in the U.S.:
Read More
Caris Life Sciences Raises $400M to Advance AI-Driven Molecular Profiling to Revolutionize Cancer Care
What You Should Know:
- Caris Life Sciences® (Caris), the a molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that the company has closed a senior secured term loan providing up to $400M in capital from OrbiMed and Braidwell. With this funding, Caris has raised approximately $1.7 billion in capital since 2018.
- Caris' comprehensive molecular profiling approach precisely analyzes DNA (Whole
Read More
Exec Hires: Greenphire Appoints Owen Newman as the CFO
What You Should Know:
- Greenphire, the global leader in financial lifecycle management for clinical trials, today announced the appointment of Owen Newman as the Chief Financial Officer (CFO).
- Newman brings more than 25 years of financial experience, most recently as CFO of Simeio, a global leader in Identity and Access Management. Newman will report directly to Greenphire's CEO, Jim Murphy.
Owen Newman Bio/Background
Newman is a mature business leader experienced at leading
Read More
7 Life Sciences Executive Predictions to Watch in 2023
Tracy Curley, CFO and interim CEO at iSpecimen
Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
